“Prognostic Factors for Regorafenib Treatment in Patients With Refractory Metastatic Colorectal Cancer: A Real-Life Retrospective Multi-Center Study”. 2023. Biomolecules and Biomedicine 23 (6): 1089–1095. https://doi.org/10.17305/bb.2023.9253.